RT @JerEscajeda: Top 5 (seven😉) articles from our #NAEMSP2019 talk 1. https://t.co/4BUC9rxz1h 2. https://t.co/kQ0vKlqkdA 3. ❌ https://t.co/…
RT @BBBleess: If you missed it in person, here are the top papers chosen by the members of the PEC Podcast for 2018. #NAEMSP2019 https://t.…
RT @BBBleess: If you missed it in person, here are the top papers chosen by the members of the PEC Podcast for 2018. #NAEMSP2019 https://t.…
If you missed it in person, here are the top papers chosen by the members of the PEC Podcast for 2018. #NAEMSP2019
RT @JerEscajeda: Top 5 (seven😉) articles from our #NAEMSP2019 talk 1. https://t.co/4BUC9rxz1h 2. https://t.co/kQ0vKlqkdA 3. ❌ https://t.co/…
RT @JerEscajeda: Top 5 (seven😉) articles from our #NAEMSP2019 talk 1. https://t.co/4BUC9rxz1h 2. https://t.co/kQ0vKlqkdA 3. ❌ https://t.co/…
RT @JerEscajeda: Top 5 (seven😉) articles from our #NAEMSP2019 talk 1. https://t.co/4BUC9rxz1h 2. https://t.co/kQ0vKlqkdA 3. ❌ https://t.co/…
RT @JerEscajeda: Top 5 (seven😉) articles from our #NAEMSP2019 talk 1. https://t.co/4BUC9rxz1h 2. https://t.co/kQ0vKlqkdA 3. ❌ https://t.co/…
RT @JerEscajeda: Top 5 (seven😉) articles from our #NAEMSP2019 talk 1. https://t.co/4BUC9rxz1h 2. https://t.co/kQ0vKlqkdA 3. ❌ https://t.co/…
RT @JerEscajeda: Top 5 (seven😉) articles from our #NAEMSP2019 talk 1. https://t.co/4BUC9rxz1h 2. https://t.co/kQ0vKlqkdA 3. ❌ https://t.co/…
RT @JerEscajeda: Top 5 (seven😉) articles from our #NAEMSP2019 talk 1. https://t.co/4BUC9rxz1h 2. https://t.co/kQ0vKlqkdA 3. ❌ https://t.co/…
Recommended reads : our 7 papers for the Top 5 article!!! #NAEMSP2019
RT @JerEscajeda: Top 5 (seven😉) articles from our #NAEMSP2019 talk 1. https://t.co/4BUC9rxz1h 2. https://t.co/kQ0vKlqkdA 3. ❌ https://t.co/…
Great presentation by one of my pre-hospital physicians and friends. Those seek a great education opportunity should check out the NAEMSP Annual Meeting next year!
RT @JerEscajeda: Top 5 (seven😉) articles from our #NAEMSP2019 talk 1. https://t.co/4BUC9rxz1h 2. https://t.co/kQ0vKlqkdA 3. ❌ https://t.co/…
RT @JerEscajeda: Top 5 (seven😉) articles from our #NAEMSP2019 talk 1. https://t.co/4BUC9rxz1h 2. https://t.co/kQ0vKlqkdA 3. ❌ https://t.co/…
@PECpodcast @PEMEMS @EMS_Boston @NAEMSP
Top 5 (seven😉) articles from our #NAEMSP2019 talk 1. https://t.co/4BUC9rxz1h 2. https://t.co/kQ0vKlqkdA 3. ❌ https://t.co/KS46nJL8LV Read: https://t.co/XVaYuft4yQ 4. https://t.co/fgPBPzUO1v 5. https://t.co/WxldaIpm5y 6. https://t.co/wAIW4NMRJ5 7. https://t
Top Papers of 2018 by @PECpodcast @EMS_Boston @JerEscajeda @PEMEMS @NAEMSP #NAEMSP2019 https://t.co/rixE6WpyYz
RT @JayHineMD: Riddle me this How can IO access (instead of IV https://t.co/2B8XOqsv9D) be a cause of worse neuro intact survival in OHCA…
RT @JayHineMD: Riddle me this How can IO access (instead of IV https://t.co/2B8XOqsv9D) be a cause of worse neuro intact survival in OHCA…
Riddle me this How can IO access (instead of IV https://t.co/2B8XOqsv9D) be a cause of worse neuro intact survival in OHCA if NOTHING we give in IV or IO improves neuro intact survival (Paramedic 2: https://t.co/cqw3SkScQY)?? @srrezaie @EMSwami
A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest. - PubMed - NCBI https://t.co/1tQi5Oa5bb
15/ #PARAMEDIC2 llegó y mostró la performance de #epinefrina en paro cardíaco extrahospitalario https://t.co/HZnxbG2erw https://t.co/qU3ejSkkkw
@Doc_Yogi Yes. Hard to go past that one. A remarkable contribution to the advancement of knowledge https://t.co/tzXL0rJVPF
ECA de la Epinefrina en el PCR extrahospitalario. https://t.co/JstXsHQ609
PARAMEDIC2: Higher 30 day survival with epinephrine for out of hospital cardiac arrest, but more severe neurologic impairment in survivors https://t.co/3gqNbwsmZj https://t.co/3gqNbwsmZj
A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest https://t.co/Dh7AKKFgwS https://t.co/Oc7abe7UiW
RT @BAlhatali: Epinephrine may improves 30 day-mortality but it may be at the cost of worse neurological outcome https://t.co/BYshMGCxI0 #E…
Epinephrine may improves 30 day-mortality but it may be at the cost of worse neurological outcome https://t.co/BYshMGCxI0 #ESEM18 #OMSB
@BJJudo Rather helpfully all these questions and more are answered in the paper: https://t.co/SRPepgFQdb
@GBeecham @psirides @GongGasGirl I find the box plots useful for understanding, though list has a log scale, so harder to interpret https://t.co/xDeSmHuOPD
RT @strachanjamie: PARAMEDIC2 trial https://t.co/wXSQE2FNl8 #ICSSOA2018
RT @strachanjamie: It has a survival benefit though Marc. #ICSSOA2018 https://t.co/H4EbIprngW
RT @katgevangelista: Take home message from the PARAMEDIC2 trial https://t.co/IC15H0wOLg #ICSSOA2018 https://t.co/GAwXWIM7kT
RT @strachanjamie: PARAMEDIC2 trial https://t.co/wXSQE2FNl8 #ICSSOA2018
RT @strachanjamie: PARAMEDIC2 trial https://t.co/wXSQE2FNl8 #ICSSOA2018
It has a survival benefit though Marc. #ICSSOA2018
PARAMEDIC2 trial https://t.co/wXSQE2FNl8 #ICSSOA2018
Now the primary author of Paramedic-2 study https://t.co/SRPepgFQdb RCT of adrenaline in OHCA #ICSSOA2018
RT @TriSTAR_anae: Prof. Gavin Perkins speaking now about the #PARAMEDIC2 trial on adrenaline use in out-of-hospital cardiac arrest; 30k-60k…
Prof. Gavin Perkins speaking now about the #PARAMEDIC2 trial on adrenaline use in out-of-hospital cardiac arrest; 30k-60k patients suffer yearly in the UK. #TSAS18 https://t.co/ORhsCe4ccc
@ADAlthousePhD @T_Allen1998 I think it's usual for cardiac arrest study. We look at quality of CPR only for some patients and some centers which have capacity (technology) to do it. Like in PARAMEDIC2: https://t.co/f1sO8D6Yo2 There is probably an observer
A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest | NEJM https://t.co/wzUuB46qpw
RT @Kangaroosteve: Paramedic 2 trial https://t.co/WUbFEtTzV6 #BASICSFPHC
RT @RemedyRDHED: PARAMEDIC-2 https://t.co/L26heqnmg1 Supporting blogs: https://t.co/Yhvr1hRKx9 https://t.co/5QM1arRAe1 https://t.co/e2rPRT…
Amazing digest and great knowledge! Thank you @RemedyRDHED @FASSGEM @UHDBTrust great work. I'm sure I saw the glint in Dr Bateman's eye prior to asking the challenging question, you handled it beautifully. Superheros
PARAMEDIC-2 https://t.co/L26heqnmg1 Supporting blogs: https://t.co/Yhvr1hRKx9 https://t.co/5QM1arRAe1 https://t.co/e2rPRTnxds #FASSGEM2018
RT @ICS_updates: A landmark high-quality pragamatic RCT of adrenaline v placebo in OHCA #paramedic2 Congratulations to Gavin Perkins (res…
RT @Kangaroosteve: Paramedic 2 trial https://t.co/WUbFEtTzV6 #BASICSFPHC
RT @Kangaroosteve: Paramedic 2 trial https://t.co/WUbFEtTzV6 #BASICSFPHC
Paramedic 2 trial https://t.co/WUbFEtTzV6 #BASICSFPHC
PARAMEDIC2 Trial A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest https://t.co/uyocCsJl6d
RT @nfpineda: Estudio reciente sobre uso de adrenalina en PCR: PARAMEDICS-2 https://t.co/g5Tg0aWaPm DOI: 10.1056/NEJMoa1806842 Adrenalina p…
RT @NEJM: #VisualAbstract: In a trial involving 8014 patients with out-of-hospital cardiac arrest, the use of epinephrine resulted in a sig…
RT @nfpineda: Estudio reciente sobre uso de adrenalina en PCR: PARAMEDICS-2 https://t.co/g5Tg0aWaPm DOI: 10.1056/NEJMoa1806842 Adrenalina p…
RT @nfpineda: Estudio reciente sobre uso de adrenalina en PCR: PARAMEDICS-2 https://t.co/g5Tg0aWaPm DOI: 10.1056/NEJMoa1806842 Adrenalina p…
RT @nfpineda: Estudio reciente sobre uso de adrenalina en PCR: PARAMEDICS-2 https://t.co/g5Tg0aWaPm DOI: 10.1056/NEJMoa1806842 Adrenalina p…
RT @nfpineda: Estudio reciente sobre uso de adrenalina en PCR: PARAMEDICS-2 https://t.co/g5Tg0aWaPm DOI: 10.1056/NEJMoa1806842 Adrenalina p…
RT @nfpineda: Estudio reciente sobre uso de adrenalina en PCR: PARAMEDICS-2 https://t.co/g5Tg0aWaPm DOI: 10.1056/NEJMoa1806842 Adrenalina p…
RT @nfpineda: Estudio reciente sobre uso de adrenalina en PCR: PARAMEDICS-2 https://t.co/g5Tg0aWaPm DOI: 10.1056/NEJMoa1806842 Adrenalina p…
RT @nfpineda: Estudio reciente sobre uso de adrenalina en PCR: PARAMEDICS-2 https://t.co/g5Tg0aWaPm DOI: 10.1056/NEJMoa1806842 Adrenalina p…
RT @nfpineda: Estudio reciente sobre uso de adrenalina en PCR: PARAMEDICS-2 https://t.co/g5Tg0aWaPm DOI: 10.1056/NEJMoa1806842 Adrenalina p…
RT @nfpineda: Estudio reciente sobre uso de adrenalina en PCR: PARAMEDICS-2 https://t.co/g5Tg0aWaPm DOI: 10.1056/NEJMoa1806842 Adrenalina p…
RT @nfpineda: Estudio reciente sobre uso de adrenalina en PCR: PARAMEDICS-2 https://t.co/g5Tg0aWaPm DOI: 10.1056/NEJMoa1806842 Adrenalina p…
RT @nfpineda: Estudio reciente sobre uso de adrenalina en PCR: PARAMEDICS-2 https://t.co/g5Tg0aWaPm DOI: 10.1056/NEJMoa1806842 Adrenalina p…
RT @nfpineda: Estudio reciente sobre uso de adrenalina en PCR: PARAMEDICS-2 https://t.co/g5Tg0aWaPm DOI: 10.1056/NEJMoa1806842 Adrenalina p…
Estudio reciente sobre uso de adrenalina en PCR: PARAMEDICS-2 https://t.co/g5Tg0aWaPm DOI: 10.1056/NEJMoa1806842 Adrenalina para todos? Tal vez la estamos dando en forma tardía? Excelente estudio a revisar completo #ChileEM #MUEUSS
イギリスは怖い研究をするな 日本でやったらメチャ叩かれそう https://t.co/2Sbe0dCJNy
ENSAYO CLINICO SOBRE EPINEFRINA EN RCP EXTRAHOSPITALARIA https://t.co/qeQ4hSN00d
RT @NEJM: #VisualAbstract: In a trial involving 8014 patients with out-of-hospital cardiac arrest, the use of epinephrine resulted in a sig…
RT @ShivaniMody: In cardiac arrest NNT to save one life with epinephrine 112.5. Compare this to early defibrillation (NNT 5) or bystander C…
RT @NEJM: Original Article: A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest https://t.co/r9uHhc4GC0 Editorial: Testing…
In cardiac arrest NNT to save one life with epinephrine 112.5. Compare this to early defibrillation (NNT 5) or bystander CPR (NNT 15)! @FOAMpodcast https://t.co/4iuwZU2ngy
RT @WBLMD: .@NEJM study shows: 0.8% 3 month survival benefit from #epinephrine in out of hospital #cardiacarrest - but significant increas…
RT @WBLMD: .@NEJM study shows: 0.8% 3 month survival benefit from #epinephrine in out of hospital #cardiacarrest - but significant increas…
.@NEJM study shows: 0.8% 3 month survival benefit from #epinephrine in out of hospital #cardiacarrest - but significant increase in critical state with no hope of neurologic recovery https://t.co/xqRQaU7Dtn #OHCA @EMNerd_
Article link: https://t.co/pH8ztK5zTv
Articles being discussed during today's #SCCMcppjc https://t.co/n4G1Hs5a6E https://t.co/pH8ztK5zTv
RT @NEJM: #VisualAbstract: In a trial involving 8014 patients with out-of-hospital cardiac arrest, the use of epinephrine resulted in a sig…
@JoffryVanG https://t.co/uJuGhXXnEd https://t.co/okjHwHTy3p Few more relevant articles if you have a quick Google.
RT @farma_summa112: La administración de adrenalina en PCR extrahospitalaria refractaria resulta en una tasa de supervivencia a 30 días sig…
RT @huoscar: Una vez más... adrenalina no mejora sobrevida con outcome neurológico favorable en PCR extra hospitalario. Si > sobrevida a 30…
RT @farma_summa112: La administración de adrenalina en PCR extrahospitalaria refractaria resulta en una tasa de supervivencia a 30 días sig…
RT @farma_summa112: La administración de adrenalina en PCR extrahospitalaria refractaria resulta en una tasa de supervivencia a 30 días sig…
RT @farma_summa112: La administración de adrenalina en PCR extrahospitalaria refractaria resulta en una tasa de supervivencia a 30 días sig…
RT @farma_summa112: La administración de adrenalina en PCR extrahospitalaria refractaria resulta en una tasa de supervivencia a 30 días sig…
RT @farma_summa112: La administración de adrenalina en PCR extrahospitalaria refractaria resulta en una tasa de supervivencia a 30 días sig…
RT @farma_summa112: La administración de adrenalina en PCR extrahospitalaria refractaria resulta en una tasa de supervivencia a 30 días sig…
RT @farma_summa112: La administración de adrenalina en PCR extrahospitalaria refractaria resulta en una tasa de supervivencia a 30 días sig…
La administración de adrenalina en PCR extrahospitalaria refractaria resulta en una tasa de supervivencia a 30 días significativamente superior respecto a placebo, aunque existe mayor riesgo de daños neurológicos #EVIDENCE https://t.co/D5vSpZyaus (Requie
RT @A_E_M_N: La adrenalina en la PCR extrahospitalaria empeora el pronóstico neurológico A Randomized Trial of Epinephrine in Out-of-Hospit…
RT @A_E_M_N: La adrenalina en la PCR extrahospitalaria empeora el pronóstico neurológico A Randomized Trial of Epinephrine in Out-of-Hospit…
La adrenalina en la PCR extrahospitalaria empeora el pronóstico neurológico A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest | NEJM https://t.co/YdGjzvMZrt
A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest | NEJM https://t.co/a18xE4hXcj
RT @proftomquinn: Looking forward to speaking to @sgulems on Monday evening about adrenaline in OHCA and more... https://t.co/wtrtKn4cfZ
RT @proftomquinn: Looking forward to speaking to @sgulems on Monday evening about adrenaline in OHCA and more... https://t.co/wtrtKn4cfZ
Looking forward to speaking to @sgulems on Monday evening about adrenaline in OHCA and more... https://t.co/wtrtKn4cfZ
Maybe these rates are truly meaningful and could allow time for certain interventions (e.g., PCI, TTM, ECMO) at receiving facilities. @nmrs244 @kurzmc @henrywangmd @adam_robinett @srrezaie #Resuscitation https://t.co/e0sdDv0IsO https://t.co/Tcwbuysb1m